China Shineway Pharmaceutical Group Dividendos y recompras
Dividendo controles de criterios 4/6
China Shineway Pharmaceutical Group es una empresa que paga dividendos con una rentabilidad actual de 6.92% que está bien cubierta por los beneficios.
Información clave
6.9%
Rentabilidad por dividendo
n/a
Rendimiento de la recompra
Rendimiento total para el accionista | n/a |
Rendimiento futuro de los dividendos | 8.5% |
Crecimiento de los dividendos | 7.3% |
Próxima fecha de pago de dividendos | n/a |
Fecha ex dividendo | n/a |
Dividendo por acción | HK$0.581 |
Ratio de pago | 37% |
Últimas actualizaciones de dividendos y recompras
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01Recent updates
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Oct 18If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity
Jun 03Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?
Apr 17China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings
Mar 14Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?
Jan 29China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Aug 03Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?
May 30We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Mar 07China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125
Sep 01China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.
Mar 11Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?
Feb 18Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?
Jan 31Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?
Jan 13What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?
Dec 25We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years
Nov 25Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: El pago de dividendos de 2877 ha sido volátil en los últimos 10 años.
Dividendo creciente: El pago de dividendos de 2877 ha aumentado en los últimos 10 años.
Rentabilidad por dividendo vs. Mercado
Rentabilidad por dividendo de China Shineway Pharmaceutical Group vs. Mercado |
---|
Segmento | Rentabilidad por dividendo |
---|---|
Empresa (2877) | 6.9% |
Suelo de mercado 25% (HK) | 3.3% |
Techo de mercado 25% (HK) | 8.1% |
Media de la industria (Pharmaceuticals) | 3.8% |
Analista de previsiones (2877) (hasta 3 años) | 8.5% |
Dividendo destacado: El dividendo de 2877(6.92%) es más alto que el 25% inferior de los pagadores de dividendos del mercado Hong Kong (3.31%).
Alto dividendo: El (6.92%) del dividendo de 2877 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Hong Kong (8.06%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (36.9%), los pagos de dividendos de 2877 están bien cubiertos por los beneficios.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: Con su razonablemente bajo ratio de pago en efectivo (36.9%), los pagos de dividendos de 2877 están bien cubiertos por los flujos de caja.